ProfileGDS5822 / ILMN_2580056
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 38% 52% 37% 43% 12% 6% 32% 52% 47% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 117.538
GSM1276600PDAC Late Ablation Control 225.452
GSM1276601PDAC Late Ablation Control 312.737
GSM1276602PDAC Late Ablation 116.943
GSM1276603PDAC Late Ablation 29.312
GSM1276604PDAC Late Ablation 36.36
GSM1303940PDAC Late Ablation_anti-CTLA4 116.132
GSM1303941PDAC Late Ablation_anti-CTLA4 227.152
GSM1303942PDAC Late Ablation_anti-CTLA4 323.447